KHK-IN-1
CAS No. 1303469-70-6
KHK-IN-1 ( Ketohexokinase inhibitor 8; KHK-IN-8 )
Catalog No. M26731 CAS No. 1303469-70-6
KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 336 | Get Quote |
|
10MG | 500 | Get Quote |
|
25MG | 806 | Get Quote |
|
50MG | 1098 | Get Quote |
|
100MG | 1485 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKHK-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionKHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
-
DescriptionKHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
-
SynonymsKetohexokinase inhibitor 8; KHK-IN-8
-
PathwayOthers
-
TargetOther Targets
-
RecptorGLP-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1303469-70-6
-
Formula Weight422.6
-
Molecular FormulaC21H26N8S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Elahi D, et al. GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide. Obesity (Silver Spring). 2008;16(7):1501-1509.
molnova catalog
related products
-
5-Furfurylidene-2-Th...
5-Furfurylidene-2-Thiobarbituric Acid is a tyrosyl-DNA phosphodiesterase inhibitor.
-
Cinepazide maleate
A cerebral vasodilator that acts as a calcium blocker; protect neuronal cells against OGD injury by suppressing OGD-induced oxidative stress and preserving mitochondrial functions.
-
PKG drug G1
PKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.